Announcements Trials
Browse Landscape

Phase

Phase 3 4

Status

Terminated 4Completed 4

Sponsor Class

INDUSTRY 4

Study Type

Interventional 4

Sponsor

Cancer Type

Other 4

Conditions

Opioid-Induced Constipation 4

Interventions

Cyclophosphamide 641Bevacizumab 552Paclitaxel 534Carboplatin 533Cisplatin 480pembrolizumab 456Gemcitabine 422Docetaxel 415Rituximab 386Radiotherapy 373Dexamethasone 351Doxorubicin 330Nivolumab 308Fluorouracil 286Capecitabine 260Etoposide 245Prednisone 244Oxaliplatin 242Erlotinib Hydrochloride 242Cytarabine 233Lenalidomide 232Trastuzumab 226Pemetrexed 220Vincristine 212fludarabine phosphate 208Leucovorin 208Cetuximab 208Filgrastim 204Bortezomib 193Methotrexate 183

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Completed × Has results × naloxegol × Clear all
NCT01395524 2017-02-23

A 12-week Extension of the Phase III Study (D3820C00004) to Assess the Effect and Safety of NKTR-118 in Patients With Non-cancer-related Pain and Opioid-induced Constipation

AstraZeneca

Phase 3 Completed
302 enrolled 13 charts
Other

Opioid-Induced Constipation

NCT01323790 2015-06-02

Assessment of Efficacy and Safety in Patients With Non-cancer-related Pain and Opioid-induced Constipation

AstraZeneca

Phase 3 Completed
700 enrolled 25 charts
Other

Opioid-Induced Constipation

NCT01309841 2015-06-01

Assessment of Efficacy and Safety in Patients With Non-cancer-related Pain and Opioid-induced Constipation

AstraZeneca

Phase 3 Completed
652 enrolled 25 charts
Other

Opioid-Induced Constipation

NCT01336205 2014-10-20

Assessment of Long-term Safety in Patients With Non-cancer-related Pain and Opioid-induced Constipation

AstraZeneca

Phase 3 Completed
844 enrolled 10 charts
Other

Opioid-Induced Constipation

Data powered by HemOnc (CC BY 4.0) Colophon âš¡